GlassScriptPhysician profile
Daniel David Anderson
NPI 1528028156
$4,245.98
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $740 · 2021: $1,268 · 2022: $923 · 2023: $417 · 2024: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $877.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sequoia Surgical, INC. | $1,254.29 | 2020-2021 | |
| Conformis, INC. | $1,092.37 | 2019-2022 | |
| Medacta USA, INC. | $650.08 | 2020 | |
| Zimmer Biomet Holdings, INC. | $273.79 | 2021-2023 | |
| Prodigy Surgical Distribution, INC. | $219.63 | 2024 | |
| Linvatec Corporation | $191.39 | 2019-2024 | Biobrace 23mm |
| Davol INC. | $144.24 | 2023 | Arista Ah Flexitip |
| Depuy Synthes Sales INC. | $136.97 | 2024 | |
| Stryker Corporation | $92.49 | 2020-2022 | |
| Smith+Nephew, INC. | $55.52 | 2019-2023 | Grafix Xc |
| Sioux Surgical INC | $42.07 | 2024 | |
| Bioventus LLC | $26.70 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.14 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.10 | 2023 | Iovera, Zilretta, Exparel |
| Amgen INC. | $16.58 | 2024 | Prolia, Evenity |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $11.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.